newsroompost
  • youtube
  • facebook
  • twitter

GNP can be used as ‘composite therapeutic agent’ in clinical trials: Dr Harsh Vardhan

GNPs also have unique physicochemical properties making them suitable for therapeutic applications including detection & diagnosis of diseases, bio-labelling and targeted drug delivery,” he said.

New Delhi : Union Health Minister Dr Harsh Vardhan on Tuesday said that the Gold Nanoparticles synthesized by the National Centre for Polar and Ocean Research and Goa University can be used as a “composite therapeutic agent” in clinical trials for anti-cancer, anti-viral and anti-diabetic drugs.

In a series of tweets, the Union Health Minister spoke about the benefits of gold nanoparticles.

Over 1 lakh blood units procured by Indian Red Cross during COVID-19 lockdown

“The National Centre for Polar and Ocean Research (NCPOR) and @GoaUniversity (Goa University) have synthesized Gold Nanoparticles (GNPs). These GNPs can be used as a composite therapeutic agent in clinical trials, especially in anti-cancer, anti-viral and anti-diabetic drugs,” the Minister tweeted.

“The study revealed the genotoxic effect of GNPs on a sulphate reducing bacteria (SRB). The GNPs display anti-bacterial properties by inhibiting SRB’s growth & its sulphide production. Metallic NPs have biomedical applications & GNPs are effective in biomedical research,” he added.

At 3.2%, India's COVID-19 mortality rate lowest in world, over 10,000 patients discharged: Harsh Vardhan

He further said that GNPs can be used for therapeutic imaging as well. “GNPs have unique optical properties too, & can be used for therapeutic imaging. GNPs also have unique physicochemical properties making them suitable for therapeutic applications including detection & diagnosis of diseases, bio-labelling and targeted drug delivery,” he said. (ANI)